Haplo graft engineering: sculpting to a T

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Hematopoietic stem cell transplantation (HSCT) is a curative therapy for hematologic malignancies.
• Alpha-beta (αβ) T cell depletion is employed in HSCT to mitigate graft-versus-host disease.
• The role of gamma delta (γδ) T cells in the context of T-cell-depleted HSCT remains an area of active investigation.

Purpose of the Study:

• To investigate the functional capacity of γδ T cells post-αβ T cell-depleted HLA-haploidentical HSCT.
• To determine the contribution of γδ T cells to antiviral and antileukemia responses.

Main Methods:

• Analysis of γδ T cell populations and their functions in patients undergoing specific HSCT protocols.
• Assessment of viral reactivation and leukemia recurrence rates in relation to γδ T cell presence and activity.

Main Results:

• γδ T cells demonstrate significant antiviral activity after transplantation.
• γδ T cells exhibit potent antileukemia effects, contributing to disease control.
• These effects are observed in the context of HLA-haploidentical HSCT depleted of αβ T cells.

Conclusions:

• γδ T cells play a crucial role in providing immune surveillance and therapeutic effects post-αβ T cell-depleted HSCT.
• Harnessing γδ T cell immunity represents a promising strategy to enhance HSCT outcomes for leukemia patients.